Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    ClinicalTrials.gov page footer was updated from revision v3.5.2 to v3.5.3, indicating a change to the site/versioning rather than the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:36:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.2, replacing the prior v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:28:22.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T01:08:16.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:25:32.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Minor version update: Revision 3.4.2 replaces 3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:18.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0, indicating a minor maintenance/version update. This appears to be a non-content change with no visible impact on core information or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T15:43:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.